SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015711
Filing Date
2023-09-13
Accepted
2023-09-13 16:45:22
Documents
13
Period of Report
2023-09-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20230912x8k.htm   iXBRL 8-K 35522
2 EX-99.1 krbp-20230912xex99d1.htm EX-99.1 15101
  Complete submission text file 0001558370-23-015711.txt   178447

Data Files

Seq Description Document Type Size
3 EX-101.SCH krbp-20230912.xsd EX-101.SCH 3129
4 EX-101.LAB krbp-20230912_lab.xml EX-101.LAB 16578
5 EX-101.PRE krbp-20230912_pre.xml EX-101.PRE 10531
7 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20230912x8k_htm.xml XML 5027
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 231253210
SIC: 2836 Biological Products, (No Diagnostic Substances)